• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估一种锝-三羟甲基甘氨酸血管破坏剂在4T1小鼠乳腺肿瘤模型中的成像效果。

Evaluation of a Tc-tricine Vascular Disrupting Agent as an Imaging in 4T1 Mouse Breast Tumor Model.

作者信息

Erfani Mostafa, Shirmardi Seyed Pezhman, Shafiei Mohammad

机构信息

Radiation Application Research School, Nuclear Science and Technology Research Institute (NSTRI), Tehran, Iran.

出版信息

Iran J Pharm Res. 2017 Summer;16(3):999-1006.

PMID:29201088
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5610754/
Abstract

Colchicine as a vascular disrupting agent creates microtubule destabilization which induces vessel blockage and consequently cell death. Accordingly, colchicines and its analogues radiolabeled with Tc may have potential for visualization of tumor. In this work, deacetylcolchicine a colchicine analogue was labeled with Tc via tricine as a coligand and characterized for its tumor targeting properties. The radiochemical stability and the biodistribution were studied in 4T1 breast tumor model bearing mice. Labeling yield of more than 90% was obtained corresponding to a specific activity of 46 MBq/µmol. biodistribution studies demonstrated that radiocomplex had high tumor to muscle and tumor to blood ratios at early time points. Planer gamma imaging of tumor bearing mice showed that this radioconjugate was able to clearly visualize tumors. According to high tumor uptake, presented radiocomplex may have a potential for targeted imaging studies.

摘要

秋水仙碱作为一种血管破坏剂会导致微管失稳,进而引起血管阻塞并最终导致细胞死亡。因此,用锝标记的秋水仙碱及其类似物可能具有肿瘤显像的潜力。在本研究中,将秋水仙碱类似物去乙酰秋水仙碱通过三羟甲基氨基甲烷作为共配体用锝进行标记,并对其肿瘤靶向特性进行了表征。在携带4T1乳腺肿瘤模型的小鼠中研究了其放射化学稳定性和生物分布。标记产率超过90%,比活度为46 MBq/µmol。生物分布研究表明,放射性复合物在早期时间点具有高的肿瘤与肌肉以及肿瘤与血液的比率。对荷瘤小鼠的平面γ显像显示,这种放射性缀合物能够清晰地显示肿瘤。基于高肿瘤摄取率,所呈现的放射性复合物可能具有靶向成像研究的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb62/5610754/4082928c5c53/ijpr-16-0999-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb62/5610754/cc70c9be42c0/ijpr-16-0999-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb62/5610754/5cf0b3d0c0ea/ijpr-16-0999-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb62/5610754/67d31fdcac31/ijpr-16-0999-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb62/5610754/0edae700cb82/ijpr-16-0999-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb62/5610754/4082928c5c53/ijpr-16-0999-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb62/5610754/cc70c9be42c0/ijpr-16-0999-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb62/5610754/5cf0b3d0c0ea/ijpr-16-0999-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb62/5610754/67d31fdcac31/ijpr-16-0999-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb62/5610754/0edae700cb82/ijpr-16-0999-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb62/5610754/4082928c5c53/ijpr-16-0999-g005.jpg

相似文献

1
Evaluation of a Tc-tricine Vascular Disrupting Agent as an Imaging in 4T1 Mouse Breast Tumor Model.评估一种锝-三羟甲基甘氨酸血管破坏剂在4T1小鼠乳腺肿瘤模型中的成像效果。
Iran J Pharm Res. 2017 Summer;16(3):999-1006.
2
Evaluation of a new radiolabeled bombesin derivative with Tc as potential targeted tumor imaging agent.评估一种以锝为标记的新型蛙皮素衍生物作为潜在靶向肿瘤显像剂的性能。
J Radioanal Nucl Chem. 2013;298(1):287-293. doi: 10.1007/s10967-013-2464-4. Epub 2013 Mar 26.
3
Tc-HYNIC-(tricine/EDDA)-FROP peptide for MCF-7 breast tumor targeting and imaging.Tc-HYNIC-(tricine/EDDA)-FROP 肽用于 MCF-7 乳腺癌肿瘤靶向和成像。
J Biomed Sci. 2018 Feb 19;25(1):17. doi: 10.1186/s12929-018-0420-x.
4
Tricine co-ligand improved the efficacy of Tc-HYNIC-(Ser)-J18 peptide for targeting and imaging of non-small-cell lung cancer.三羟甲基甘氨酸共配体提高了 Tc-HYNIC-(Ser)-J18 肽用于非小细胞肺癌靶向和成像的疗效。
Biomed Pharmacother. 2018 Aug;104:325-331. doi: 10.1016/j.biopha.2018.05.037. Epub 2018 May 15.
5
Evaluation of tricine and EDDA as Co-ligands for 99mTc-labeled HYNIC-MSH analogs for melanoma imaging.用于黑色素瘤成像的99mTc标记的HYNIC-MSH类似物中,将三羟甲基氨基甲烷(tricine)和乙二胺-N,N'-二乙酸(EDDA)作为共配体的评估。
Anticancer Agents Med Chem. 2015;15(1):122-30. doi: 10.2174/1871520614666140825123150.
6
Effects of coligand variation on the in vivo characteristics of Tc-99m-labeled interleukin-8 in detection of infection.共配体变化对99m锝标记白细胞介素-8在感染检测中的体内特性的影响。
Bioconjug Chem. 2002 Mar-Apr;13(2):370-7. doi: 10.1021/bc015579k.
7
[99mTc]HYNIC-RGD for imaging integrin alphavbeta3 expression.用于整合素αvβ3表达成像的[99mTc]HYNIC-RGD
Nucl Med Biol. 2006 Nov;33(8):945-52. doi: 10.1016/j.nucmedbio.2006.09.001.
8
New neurotensin analogue radiolabeled by 99m-technetium as a potential agent for tumor identification.新型神经降压素类似物经 99m-锝标记后可作为肿瘤识别的潜在试剂。
Chem Biol Drug Des. 2018 Jan;91(1):304-313. doi: 10.1111/cbdd.13082. Epub 2017 Sep 12.
9
An improved Tc-HYNIC-(Ser)-LTVSPWY peptide with EDDA/tricine as co-ligands for targeting and imaging of HER2 overexpression tumor.一种新型 Tc-HYNIC-(Ser)-LTVSPWY 肽,以 EDDA/tricine 作为共配体,用于靶向和成像过表达 HER2 的肿瘤。
Eur J Med Chem. 2018 Jan 20;144:767-773. doi: 10.1016/j.ejmech.2017.12.037. Epub 2017 Dec 13.
10
(99m)technetium-HYNIC(tricine/TPPTS)-Aca-bombesin(7-14) as a targeted imaging agent with microSPECT in a PC-3 prostate cancer xenograft model.(99m)锝-HYNIC(三羟甲基氨基甲烷/TPPTS)-Aca-蛙皮素(7-14)作为一种靶向成像剂,在 PC-3 前列腺癌异种移植模型中进行 microSPECT 研究。
Mol Pharm. 2011 Aug 1;8(4):1165-73. doi: 10.1021/mp200014h. Epub 2011 Jun 30.

本文引用的文献

1
Synthesis and evaluation of a 99mTc-labeled tubulin-binding agent for tumor imaging.
J Labelled Comp Radiopharm. 2014 May 30;57(6):419-24. doi: 10.1002/jlcr.3200. Epub 2014 Apr 16.
2
Preparation and biological evaluation of [(99m)Tc/EDDA/Tricine/HYNIC(0), BzThi(3)]-octreotide for somatostatin receptor-positive tumor imaging.[(99m)Tc/EDDA/Tricine/HYNIC(0), BzThi(3)]-奥曲肽的制备及用于生长抑素受体阳性肿瘤显像的生物学评价。
Cancer Biother Radiopharm. 2013 Apr;28(3):240-7. doi: 10.1089/cbr.2012.1270. Epub 2013 Mar 6.
3
Preclinical evaluation of a new bombesin analog for imaging of gastrin-releasing peptide receptors.新型蛙皮素类似物用于胃泌素释放肽受体成像的临床前评估。
Cancer Biother Radiopharm. 2011 Jun;26(3):309-16. doi: 10.1089/cbr.2010.0912. Epub 2011 Jun 28.
4
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008.2008 年全球癌症负担估计值:GLOBOCAN 2008。
Int J Cancer. 2010 Dec 15;127(12):2893-917. doi: 10.1002/ijc.25516.
5
Preparation and in-vivo evaluation of (188)Re(CO)(3)-colchicine complex for use as tumor-targeting agent.(188)Re(CO)(3)-秋水仙碱配合物的制备及其作为肿瘤靶向药物的体内评价。
Cancer Biother Radiopharm. 2008 Dec;23(6):741-8. doi: 10.1089/cbr.2008.0509.
6
How do HYNIC-conjugated peptides bind technetium? Insights from LC-MS and stability studies.HYNIC 偶联肽如何结合锝?来自液相色谱 - 质谱联用和稳定性研究的见解。
Dalton Trans. 2007 Nov 21(43):4998-5007. doi: 10.1039/b705111e. Epub 2007 Sep 25.
7
Colchicine today.如今的秋水仙碱。
Joint Bone Spine. 2006 Dec;73(6):672-8. doi: 10.1016/j.jbspin.2006.03.006. Epub 2006 Sep 1.
8
99mTc-labeling of colchicine using [99mTc(CO)3(H2O)3]+ and [99mTc triple bond N]2+ core for the preparation of potential tumor-targeting agents.使用[99mTc(CO)3(H2O)3]+和[99mTc三键N]2+核心对秋水仙碱进行99mTc标记以制备潜在的肿瘤靶向剂。
Bioorg Med Chem. 2006 Feb 1;14(3):793-9. doi: 10.1016/j.bmc.2005.09.006. Epub 2005 Nov 11.
9
Inhibition of mitosis by glycopeptide dendrimer conjugates of colchicine.秋水仙碱糖肽树枝状聚合物共轭物对有丝分裂的抑制作用。
Chemistry. 2005 Jun 20;11(13):3941-50. doi: 10.1002/chem.200401294.
10
Technetium Complexes of a Hydrazinonicotinamide-Conjugated Cyclic Peptide and 2-Hydrazinopyridine: Synthesis and Characterization.
Inorg Chem. 1999 Mar 22;38(6):1326-1335. doi: 10.1021/ic980973o.